The CDC currently lists no active Level 3 Travel Health Notices—designating "reconsider nonessential travel" for outbreaks posing high risk with limited precautions—with recent updates confined to Level 2 "practice enhanced precautions" for meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10). Stable H5N1 avian influenza epidemiology, featuring 71 sporadic U.S. human cases since 2024 but no detected person-to-person transmission per CDC surveillance, further supports trader consensus at 62% implied probability for "No" by December 31. Ongoing monitoring of global polio (Level 2) and dengue (Level 1) shows no escalation signals, reflecting low baseline rates for Level 3 activations absent widespread epidemics.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourLe CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Le CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Oui
$94,938 Vol.
$94,938 Vol.
Oui
$94,938 Vol.
$94,938 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...The CDC currently lists no active Level 3 Travel Health Notices—designating "reconsider nonessential travel" for outbreaks posing high risk with limited precautions—with recent updates confined to Level 2 "practice enhanced precautions" for meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10). Stable H5N1 avian influenza epidemiology, featuring 71 sporadic U.S. human cases since 2024 but no detected person-to-person transmission per CDC surveillance, further supports trader consensus at 62% implied probability for "No" by December 31. Ongoing monitoring of global polio (Level 2) and dengue (Level 1) shows no escalation signals, reflecting low baseline rates for Level 3 activations absent widespread epidemics.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes